Rob Davis, Merck CEO
Hunting deals on all fronts, Merck enlists drug discovery biotech on search for protein modulators
At a recent quarterly investor call, Merck CEO Rob Davis hinted at a streak of deals to come as he promised to be “appropriately aggressive …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
